<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: bromide</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'bromide'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22bromide%22&t=%22bromide%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:56:37 +0100</lastBuildDate>
        <item>
            <title>Research – Synthetic Lipoid Compounds: DDA</title>
            <link>http://www.medworm.com/index.php?rid=3954263&amp;cid=t_250722_87_f&amp;fid=39260&amp;url=http%3A%2F%2Fvaccineblogs.com%2Fresearch-synthetic-lipoid-compounds-dda%2F</link>
            <description>Step 1. Read about vaccine ingredient causing delayed-type hypersensitivity.
&amp;#8220;In 1966 Gall, in a survey of more than 100 chemicals, concluded that aliphatic compounds, containing 12 or more carbons in their chains, have outstanding adjuvant properties&amp;#8230;Dimethyl-dioctadecyl ammonium bromide (DDA) is the only lipoid amine that has been extensively tested in many experimental systems and reviewed&amp;#8230;In general DDA has proven to be very effective in inducing delayed-type hypersensitivity (DTH) (a marker for cell-mediated immunity (CMI)), humoral anditbodies and resistance to challenge with virulent viruses.&amp;#8221;
Stewart-Tull, D. (1995). The Theory and Practical Application of Adjuvants. pp 39-40


Step 2. Go to Toxnet. http://toxnet.nlm.nih.gov

Slap in Dimethyl-dioctadecyl amm...</description>
            <author>Vaccine Blogs</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3954263</comments>
            <pubDate>Fri, 10 Sep 2010 05:06:00 +0100</pubDate>
            <guid isPermaLink="false">3954263</guid>        </item>
        <item>
            <title>Relistor may weaken the GI wall</title>
            <link>http://www.medworm.com/index.php?rid=3823169&amp;cid=t_250722_154_f&amp;fid=35946&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCanadianMedicine%2F%7E3%2FO_Orz-eNKxk%2Frelistor-may-weaken-gi-wall.html</link>
            <description>When to bewareAs all meds do, mythylnaltrexone bromide (Relistor) has its share of possible side effects, the most common being dizziness, flatulence, mild diarrhea, nausea, stomach pain, vomiting, and hyperhidrosis. Severe reactions include a serious case of any already mentioned, or allergic reactions.Today, Health Canada and Wyeth Canada added a new possible adverse reaction to the list: a heightened risk of gastrointestinal perforation, especially in those with GI cancers and other conditions that could weaken the gastrointestinal wall.When Relistor came onto the scene – it was approved by Health Canada on March 28, 2008 – it relieved opioid-induced constipation in palliative-care patients with incurable cancers, end-stage COPD from emphysema, heart failure, Alzheimer’s disease, ...</description>
            <author>Canadian Medicine</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3823169</comments>
            <pubDate>Wed, 04 Aug 2010 22:08:00 +0100</pubDate>
            <guid isPermaLink="false">3823169</guid>        </item>
        <item>
            <title>FDA Clears Concern over Spiriva Inhaler</title>
            <link>http://www.medworm.com/index.php?rid=3182247&amp;cid=t_250722_111_f&amp;fid=36048&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2Ftg0467tgi6A%2F</link>
            <description>Spiriva (tiotropium bromide) is an inhaled medication used to prevent exacerbations (&amp;#8221;attacks&amp;#8221;) caused by COPD, or chronic obstructive pulmonary disease. It&amp;#8217;s taken once per day. There were concerns a while ago about a possible connection between using Spiriva and experiencing a higher risk of stroke and/or heart attacks.
Courtesy of Pfizer Inc.
When this concern was raised, the FDA investigated and has come to the conclusion that this is not an issue with the medication. The FDA came to this conclusion when it and the FDA Pulmonary &amp;#8211; Allergy Drugs Advisory Committee reviewed a 4-year study involving 5,992 patients.
According to the findings,

there was no significant increase in the risk of stroke [0.95 (95% CI 0.70, 1.29)], heart attack [0.73 (95% CI 0.53, 1.00)],...</description>
            <author>A Hearty Life</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3182247</comments>
            <pubDate>Mon, 18 Jan 2010 09:42:20 +0100</pubDate>
            <guid isPermaLink="false">3182247</guid>        </item>
        <item>
            <title>House - Episode 18 (Season Three): &amp;#8220;Airborne&amp;#8221;</title>
            <link>http://www.medworm.com/index.php?rid=536358&amp;cid=t_250722_85_f&amp;fid=34692&amp;url=http%3A%2F%2Fpolitedissent.com%2Farchives%2F1620</link>
            <description>A nice brisk episode of House with two good medical mysteries. One involves a woman hospitalized with neurological symptoms, and the second involved House and Cuddy stranded on a plane with a possible meningitis epidemic. Spoilers follow, so make sure you watch the episode first&amp;#8230;

The first story concerns a 58 year-old woman who presents to the clinic after suffering blurry vision and a fainting spell. Her medical history is negative, except for a recent trip to Caracas where she went a little wild and indulged in drugs, sex, and &amp;#8212; one presumes &amp;#8212; rock and roll. Wilson finds a scopolamine patch (used to treat motion sickness) behind her ear, and blames the symptoms on this. He removes the patch and sends her on her way, but she has a seizure as she leaves the clinic. She i...</description>
            <author>Polite Dissent</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=536358</comments>
            <pubDate>Wed, 11 Apr 2007 13:45:04 +0100</pubDate>
            <guid isPermaLink="false">536358</guid>        </item>
    </channel>
</rss>

